[1] |
LUQUE-RAMÍREZ M, ESCOBAR-MORREALE H F. Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity[J]. Curr Hypertens Rep, 2014, 16(12):500.
|
[2] |
DI PIETRO M, PARBORELL F, IRUSTA G, et al.Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model[J]. Endocrinology, 2015, 156(4): 1453-1463.
|
[3] |
PALOMBA S, LA SALA G B. Pregnancy complications in women with polycystic ovary syndrome: importance of diagnostic criteria or of phenotypic features?[J]. Hum Reprod, 2016, 31(1): 223-224.
|
[4] |
LEGRO R S, BRZYSKI R G, DIAMOND M P, et al.Letrozole versus clomiphene for infertility in the polycystic ovary syndrome[J]. N Engl J Med, 2014, 371(2): 119-129.
|
[5] |
华飞. 多囊卵巢综合征患者合并胰岛素抵抗、代谢综合征及抑郁症的研究与评估[D]. 苏州:苏州大学,2016.
|
[6] |
赵玲玲. 多囊卵巢综合征患者代谢特征与胰岛素抵抗的相关性分析[D]. 长春:吉林大学,2015.
|
[7] |
AMATO M C, VESCO R, VIGNERI E, et al.Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance[J]. J Endocrinol Invest, 2015, 38(12): 1319-1326.
|
[8] |
YILMAZ H, CELIK H T, OZDEMIR O, et al.Serum galectin-3 levels in women with PCOS[J]. J Endocrinol Invest, 2014, 37(2):181-187.
|
[9] |
王立娜, 郑丽娜, 芦珊珊. 吡格列酮对多囊卵巢综合征患者血清CRP、IL-6、TNF-α水平的影响[J]. 山东医药,2015,55(38):58-59.
|
[10] |
陈沛林,陈光元,谢家滨,等. 血清炎症因子在多囊卵巢综合征患者中的表达及其临床意义[J]. 海南医学,2016,27(12):1945-1947.
|
[11] |
李丹, 李玉洁, 杨庆,等. 血管内皮功能障碍与动脉粥样硬化研究进展[J]. 中国实验方剂学杂志, 2012, 18(8):272-276.
|
[12] |
车业娜. 雄激素导致PCOS发病机理的研究[D]. 南京:南京大学,2012.
|
[13] |
LONG X, LI R, YANG Y, et al.Overexpression of IL-18 in the proliferative phase endometrium of patients with polycystic ovary syndrome[J]. Reprod Sci, 2017, 24(2): 252-257.
|
[14] |
COVINGTON J D, TAM C S, PASARICA M, et al.Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise[J]. Biochimie, 2014, 124: 27-33.
|
[15] |
SPRITZER P M, LECKE S B, SATLER F, et al.Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome[J]. Reproduction, 2015, 149(5): R219-R227.
|
[16] |
SHERLOCK J P, TAYLOR P C, BUCKLEY C D.The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases[J]. Curr Opin Rheumatol, 2015, 27(1):71-75.
|